40 million more women would lose access to abortion care if a federal court revokes the use of a key drug in medication abortions, data from the abortion rights group NARAL shows. Why it matters: A U.S. District Court in Texas could decide this month to temporarily block the FDA's authorization of mifepristone, one of
40 million more women would lose access to abortion care if a federal court revokes the use of a key drug in medication abortions, data from the abortion rights group NARAL shows.
A U.S. District Court in Texas could decide this month to temporarily block the FDA’s authorization of mifepristone, one of two drugs used to end pregnancies. Doing so would effectively result in a nationwide ban on a method that accounts for most abortions in the U.S.
“It’s the biggest thing since [the Dobbs decision],” said Mini Timmaraju, president of NARAL Pro-Choice America, adding that it shows how anti-abortion groups “can go after abortion” even in states that protect access.
Discover more from News Facts Network
Subscribe to get the latest posts sent to your email.
